Dexcom (DXCM) Receivables (2010 - 2026)

Dexcom (DXCM) has 17 years of Receivables data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Receivables fell 5.5% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 5.5% YoY) and the FY2025 annual result came in at $1.2 billion, up 20.78% from the prior year.
• Receivables declined to $1.1 billion in Q1 2026 per DXCM's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Receivables topped out at $1.4 billion in Q2 2025 and bottomed at $554.8 million in Q1 2022.
• The 5-year median for Receivables is $981.9 million (2023), against an average of $917.0 million.
• The widest annual swing landed in 2024, when Receivables jumped 53.12%; it then declined 5.5% in 2026.
• Tracing DXCM's Receivables over 5 years: stood at $722.3 million in 2022, then jumped by 35.94% to $981.9 million in 2023, then increased by 3.97% to $1.0 billion in 2024, then gained by 20.78% to $1.2 billion in 2025, then decreased by 10.34% to $1.1 billion in 2026.
• Per Business Quant, the three latest DXCM Receivables figures stand at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.1 billion (Q3 2025).

Peer Comparison